NuvOx Pharma Receives Phase I STTR Grant from NINDS for Preclinical Studies in Stroke

Tucson, AZ, October 12, 2021 --( NuvOx Pharma, a Tucson based biotechnology company, has received a $478,000 NIH Phase I Small Business Technology Transfer (STTR) grant from the National Institute of Neurological Disorders and Stroke (NINDS) under award number R41NS124450. Click here to read more.

Recent Posts

See All